Table 3 Sub-group analyses: Associations between MMC and STI outcomes among men in the HIPSS study
HIV | PR | 95% CI | HSV-2 | PR (95% CI) | |
|---|---|---|---|---|---|
Subgroup 1: Coinfected with at least one other STI | |||||
 unadjusted | 0.624 (0.513, 0.760) | 0.513 | 0.760 | unadjusted | 0.754 (0.657, 0.865) |
 TMLE | 0.713 (0.630, 0.807) | 0.630 | 0.807 | TMLE | 0.916 (0.849, 0.987) |
 PSFM | 0.763 (0.609, 0.956) | 0.609 | 0.956 | PSFM | 0.896 (0.737, 1.090) |
 IPTW | 0.770 (0.629, 0.943) | 0.629 | 0.943 | IPTW | 0.902 (0.808, 1.008) |
Subgroup 2: Not Coinfected with any other STI | |||||
 unadjusted | 0.256 (0.109, 0.599) | 0.109 | 0.599 | unadjusted | 0.707 (0.574, 0.869) |
 TMLE | 0.419 (0.248, 0.709) | 0.248 | 0.709 | TMLE | 1.042 (0.918, 1.183) |
 PSFM | 0.272 (0.097, 0.763) | 0.097 | 0.763 | PSFM | 0.879 (0.678, 1.141) |
 IPTW | 0.309 (0.143, 0.666) | 0.143 | 0.666 | IPTW | 0.887 (0.705, 1.115) |